Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-GT™
HUGO-Ab™
Humanized Target Gene Models
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Regular Transgenic
PiggyBac Transgenesis
BAC Transgenic
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Drug Discovery and Development
Antibody Discovery Platform
HUGO-Mab™
HUGO-Light™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Metabolic & Cardiovascular
Obesity
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Innovative Drug R&D
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
Peer-Reviewed Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Corporate Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
HomeMouseAtlas
C57BL/6JCya-Robo3em1flox/Cya
Request a Product Quote
Select products from our catalogs and submit your request. Our team will get back to you with detailed information.
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Catalog Type
Product Name
Main Area of Research
How did you hear about us?
Additional Comments
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.

C57BL/6JCya-Robo3em1flox/Cya

Common Name
Robo3-flox
Product ID
S-CKO-18151
Backgroud
C57BL/6JCya
Strain ID
CKOCMP-19649-Robo3-B6J-VB
Status
Research and Development
When using this mouse strain in a publication, please cite “Robo3-flox Mouse (Catalog S-CKO-18151) were purchased from Cyagen.”
cKO Models
Product Type
Age
Genotype
Sex
Quantity
The standard delivery applies for a guaranteed minimum of three heterozygous carriers. Breeding services for homozygous carriers and/or specified sex are available.
+
cKO Models
Basic Information
Strain Name
Robo3-flox
Strain ID
CKOCMP-19649-Robo3-B6J-VB
Gene Name
Robo3
Product ID
S-CKO-18151
Gene Alias
Rig1, Rbig1, Rig-1, Robo3a, Robo3b
Background
C57BL/6JCya
NCBI ID
19649 (Mouse)
Modification
Conditional knockout
Chromosome
Chr 9 (Mouse)
Phenotype
MGI:1343102
Datasheet
Click here to download >>
Application
--
More
Rare Disease Data Center >>
Strain Description
Ensembl Transcript ID
ENSMUST00000115038
NCBI Transcript ID
NM_001164767
Target Region
Exon 2~3
Size of Effective Region
~1.7 kb
Overview of Gene Research
Robo3, a member of the Roundabout (ROBO) gene family, is an unconventional Robo receptor. It plays crucial roles in axon crossing of the CNS midline, especially in the development of commissural axons that connect both sides of the nervous system. It is associated with the SLIT/ROBO signaling pathway, which is important for the nervous system and embryonic development [1,3].

Many studies using transgenic mouse models have shown that Robo3 expression is mandatory for commissural axon guidance to the floor plate [1]. Mutations in human ROBO3 are responsible for horizontal gaze palsy with progressive scoliosis (HGPPS), an autosomal recessive disorder. Patients with HGPPS display midline crossing defects, including congenital absence or severe restriction of horizontal gaze and progressive scoliosis [2,3,4,6]. In non-M3 acute myeloid leukemia, high ROBO3 expression is associated with increased age at diagnosis, poorer risk classification, higher rates of TP53 and RUNX1 mutations, and significantly worse overall and event-free survival. It may also be a biomarker of inferior prognosis [5]. In pancreatic carcinoma, ROBO3 expression is up-regulated, and over-expression promotes cancer cell growth, invasion, and metastasis [7].

In conclusion, Robo3 is essential for the development of commissural circuits in the nervous system. The study of Robo3 through gene-knockout or conditional-knockout mouse models has revealed its role in HGPPS, non-M3 acute myeloid leukemia, and pancreatic carcinoma. Understanding Robo3's function provides insights into the development of the nervous system and the pathogenesis of related diseases, which may contribute to the development of new treatment strategies.

References:
1. Friocourt, François, Chédotal, Alain. 2017. The Robo3 receptor, a key player in the development, evolution, and function of commissural systems. In Developmental neurobiology, 77, 876-890. doi:10.1002/dneu.22478. https://pubmed.ncbi.nlm.nih.gov/28033646/
2. Pinero-Pinto, Elena, Pérez-Cabezas, Verónica, Tous-Rivera, Cristina, Benítez-Lugo, María-Luisa, Sánchez-González, María Carmen. 2020. Mutation in ROBO3 Gene in Patients with Horizontal Gaze Palsy with Progressive Scoliosis Syndrome: A Systematic Review. In International journal of environmental research and public health, 17, . doi:10.3390/ijerph17124467. https://pubmed.ncbi.nlm.nih.gov/32580277/
3. Harahsheh, Ehab Y, Moxley, Lauren E, Al-Amin, Matu, Deniz, Adnan, Osundiji, Mayowa. 2025. 20 years of ROBO3-related horizontal gaze palsy with progressive scoliosis: a mini-review. In Neurogenetics, 26, 30. doi:10.1007/s10048-025-00811-0. https://pubmed.ncbi.nlm.nih.gov/39960500/
4. Yi, Sheng, Qin, Zailong, Zhou, Xunzhao, Chen, Biyan, Luo, Jingsi. 2023. Early onset horizontal gaze palsy and progressive scoliosis due to a noncanonical splicing-site variant and a missense variant in the ROBO3 gene. In Molecular genetics & genomic medicine, 11, e2215. doi:10.1002/mgg3.2215. https://pubmed.ncbi.nlm.nih.gov/37330975/
5. Cai, Zhimei, Wei, Jifeng, Chen, Ze, Wang, Haiqing. 2021. High ROBO3 expression predicts poor survival in non-M3 acute myeloid leukemia. In Experimental biology and medicine (Maywood, N.J.), 246, 1184-1197. doi:10.1177/1535370220988246. https://pubmed.ncbi.nlm.nih.gov/33541130/
6. Sim, Bryan, Ng, Janice Wan Zhen, Sim, Donald Yuhui, Roca, Xavier, Jamuar, Saumya Shekhar. 2023. A novel intronic variant in ROBO3 associated with horizontal gaze palsy with progressive scoliosis: case report and literature review. In Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus, 27, 359-363. doi:10.1016/j.jaapos.2023.08.017. https://pubmed.ncbi.nlm.nih.gov/37931836/
7. Han, Shilong, Cao, Chuanwu, Tang, Tao, Zhang, Xiaoping, Li, Maoquan. 2015. ROBO3 promotes growth and metastasis of pancreatic carcinoma. In Cancer letters, 366, 61-70. doi:10.1016/j.canlet.2015.06.004. https://pubmed.ncbi.nlm.nih.gov/26070964/
Quality Control Standard
Sperm Test

Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.

Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.

Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Inquiry Details
Main Area of Research
Service(s) of Interest
Gene of Interest
Project Details
How did you hear about us?
Contact Information
Full Name
Email
Phone Number
+
-
Organization
Job Role
Country
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our  Privacy Policy  for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCorporate OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2025 Cyagen. All rights reserved.
Privacy Policy
Site Map
Global Antibody Drug Industry Development BlueBook (Frost & Sullivan)
Key Insights
The industry is undergoing a rapid transformation driven by next-generation modalities, globalized markets, and upstream technological innovations.
  • Market Structural Shift: Monoclonal antibodies drive steady growth, but ADCs and bispecifics are rapidly accelerating, reshaping the market with higher-value innovations.
  • Chinese Market Globalization: China is actively expanding globally, evidenced by a surge in high-value cross-border license-out deals.
  • Technology-Driven Efficiency: Advanced discovery engines—exemplified by Cyagen's HUGO-Ab platform and AI algorithms—are streamlining candidate screening, optimizing molecular design, and localizing the upstream supply chain.
  • Oncology-Focused Innovation: R&D pipelines remain heavily concentrated on high-incidence malignancies like non-small cell lung cancer, utilizing complex modalities to combat clinical resistance.
Now Available for Download
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research